The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics will attract researchers from around the world to discuss innovations in drug development, target selection, the impact of new discoveries in cellular and molecular biology, and early clinical trials. Reporters and cancer center PIOs who are interested in attending the conference should review the AACR’s press and PIO registration policy and submit a request for complimentary registration.

Request for complimentary registration Contact AACR’s public relations team

Embargo policy

Please read the following information closely regarding the embargo policy for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. You may contact Julia Gunther at [email protected] with additional questions.

IMPORTANT DATES AND TIMES

Regular and late-breaking abstract titles and presenters (no data) are available now on the AACR’s website.

• Regular abstract text will be posted on October 4, 2023, at noon ET on the conference app
• Late-breaking abstract text will be posted on October 11, 2023, at noon ET on the conference app
• Any abstract selected for the official meeting press program will be posted during the conference at the beginning of the session where the study is being presented

OUTSIDE PRESS RELEASES

Public information officers or public relations firms representing academia or industry with abstracts in the meeting may issue press releases containing only information that is available on the AACR’s website and the conference app. Any information beyond what is in the abstract is embargoed until the beginning of the session where the study is being presented.

Institutions or companies planning to promote abstracts that are selected for the official meeting press program must contact Julia Gunther at [email protected] to ensure all embargo policies are followed.

EMBARGO VIOLATIONS: PRESENTERS AND PUBLIC RELATIONS

Presenters, their companies/institutions, and affiliated public relations representatives who violate the meeting’s embargo policy as outlined above could jeopardize an abstract’s placement in the scientific program and press events.

EMBARGO VIOLATIONS: media

Individuals registered as press for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics agree to abide by all embargoes. In advance of the meeting, the AACR may provide abstracts, press releases, and other materials under embargo to facilitate accurate and comprehensive reporting. Failure to abide by the meeting’s embargo policy may result in removal from AACR pre-embargo press lists and dismissal from current and future AACR meetings.